Primary beta-sarcoglycanopathy manifesting as recurrent exercise-induced myoglobinuria

Neuromuscular Disorders

Volumn 11, Issue 4, 2001, Pages 389-394

  Cagliani, R ^a   Comi, G P ^a   Tancredi, L ^a   Sironi, M ^b   Fortunate, F ^a   Giorda, R ^b   Bardoni, A ^b   Moggio, M ^a   Prelle, A ^a   Bresolin, N ^a,b   Scarlato, G ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b SCIENTIFIC INSTITUTE   (Italy)

Author keywords

Limb girdle muscular dystrophies 2E; Myoglobinuria; Primary sarcoglycanopathy

Indexed keywords

DYSTROPHIN; SARCOGLYCAN;

ARTICLE; CASE REPORT; CHILD; ELECTROMYOGRAM; EXERCISE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIMB GIRDLE MUSCULAR DYSTROPHY; MALE; MUSCLE BIOPSY; MYOGLOBINURIA; PRIORITY JOURNAL; SEQUENCE ANALYSIS; WESTERN BLOTTING;

BASE SEQUENCE; CHILD; CYTOSKELETAL PROTEINS; DYSTROGLYCANS; EXERCISE; HETEROZYGOTE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; MUTATION; MYOGLOBINURIA; RECURRENCE;

EID: 0035021945     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(00)00207-8     Document Type: Article

References (22)

1. Kaplan JC. Neuromuscular disorders: gene location. Neuromuscular Disord 2000;10(4,5):I-IX.
2. Driss A, Amouri R, Ben Hamida C, et al. A new locus for autosomal recessive limb-girdle muscular dystrophy in a large consanguineus Tunisian family maps to chromosome 19q13.3. Neuromuscular Disord 2000;10(4,5):240-246.
3. Noguchi S, McNally EM, Ben Othame K, et al. Mutations in the dystrophin-associated protein gamma sarcoglycan in chromosome 13 muscular dystrophy. Science 1995;270(5237):819-822.
4. Roberds SL, Leturcq F, Allamand V, et al. Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell 1994;78(4):625-633.
5. Lim LE, Duclos F, Broux O, et al. Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat Genet 1995;11(3):257-265.
6. Bonnemann CG, Modi R, Noguchi S, et al. Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet 1995;11(3):266-273.
7. Nigro V, Moreira ED, Piluso G, et al. Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta sarcoglycan gene. Nat Genet 1996;14(2):195-198.
8. Bonnemann CG, Passos-Bueno MR, McNally EM, et al. Genomic screening for beta-sarcoglycan gene mutations: missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E). Hum Mol Genet 1996;5(12):1953-1961.
9. Bonnemann CG, Wong J, Ben Hamida C, Ben Hamida M, Hentati F, Kunkel LM. LGMD 2E in Tunisia is caused by a homozygous missense mutation in beta-sarcoglycan exon 3. Neuromusc Dis 1998;8(3,4):193-197.
10. Barresi R, Confalonieri V, Lanfossi M, et al. Concomitant deficiency of β and γ-sarcoglycans in 20 α-sarcoglycan (adhalin)-deficiency patients: immunohistochemical analysis and clinical aspects. Acta Neuropathol 1997;94(1):28-35.
11. Eymard B, Romero NB, Leturcq F, et al. Primary adhalinopathy (α-sarcoglycanopathy): clinical pathologic and genetic correlation in 20 patients with autosomal recessive muscular dystrophy. Neurology 1997;48(5):1227-1234.
12. Dubowitz V. Muscle biopsy, a pratical approach. 2nd ed. Philadelphia: Baillière Tindall, 1985.
13. Nicholson LV, Davison K, Falkous G, et al. Dystrophin in skeletal muscle. Immunoreactivity in patients with Xp21 muscular dystrophy. J Neurol Sci 1989;94(1-3):137-146.
14. Prelle A, Comi GP, Tancredi L, et al. Sarcoglycan deficiency in a large Italian population of myopathic patients. Acta Neuropathol 1998;96(5):509-514.
15. McNally E, Passos-Bueno M, Bonnemann C, et al. Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation. Am J Hum Genet 1996;59(5):1040-1047.
16. Piccolo F, Roberds SL, Jeanpierre M, et al. Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity. Nat Genet 1995;10(2):243-245.
17. Carrié A, Piccolo F, Leturcq F, et al. Mutational diversity and hotspots in the α-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD-2D). J Med Genet 1997;34(6):470-475.
18. Duclos F, Broux O, Bourg N, et al. β-Sarcoglycan: genomic analysis and identification of a novel missense mutation in the LGMD-2E Amish isolate. Neuromuscular Disord 1998;8(1):30-38.
19. Blake DJ, Kroger S. The neurobiology of duchenne muscular dystrophy: learning lessons from muscle? Trends Neurosci 2000;23(3):92-99.
20. Comi GP, Prelle A, Bresolin N, et al. Clinical variability in Becker muscular dystrophy Genetic, biochemical and immunohistochemical correlates. Brain 1994;117(Pt1):1-14.
21. Figarella-Branger D, Baeta Machado AM, Putzu GA, Malzac P, Voelckel NA, Pellissier JF. Exertional rhabdomyolysis and exercise intollerance revealing dystrophynopathies. Acta Neuropathol 1997;94(1):48-53.
22. Doriguzzi C, Palmucci L, Mongini T, Chiadò-Piat L, Restagno G, Ferrone M. Exercise intollerance and recurrent myoglobinuria as the only expression of Xp21 Becker type muscular dystrophy. J Neurol 1993;240(5):269-271.